JohnHowardRexMD

Physician

Dr. Rex is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1987 - 1991
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1984 - 1987
Baylor College of MedicineClass of 1982

PubMed

1 citations
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps.
Valeria Gigante, Richard A Alm, Daniela Melchiorri, Tamarie Rocke, Cesar A Arias
Antimicrobial Agents and Chemotherapy. 2024-08-07
1 citations
Reply to Kaye and Belley, "Third-Generation Cephalosporin-ResistantAre Critical Priority Pathogens, Too!"
Mark S Butler, Valeria Gigante, Hatim Sati, Sarah Paulin, Laila Al-Sulaiman
Antimicrobial Agents and Chemotherapy. 2022-04-19
129 citations
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed.
Mark S Butler, Valeria Gigante, Hatim Sati, Sarah Paulin, Laila Al-Sulaiman
Antimicrobial Agents and Chemotherapy. 2022-03-15

F2G Announces FDA Filing Acceptance of New Drug Application for Olorofim for the Treatment of Invasive Fungal InfectionsDecember 19th, 2022
F2G Announces Data from Phase 2b Study at ID Week 2022 Showing Positive Therapeutic Response in Patients with Invasive Fungal Infections Treated with OlorofimOctober 21st, 2022
Results from Phase 2 THOR-2 Study Showed Improved Rates of Recurrence-Free Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations Treated with Erdafitinib Versus ChemotherapyOctober 25th, 2023
Join now to see all